Literature DB >> 20450923

Several tetratricopeptide repeat (TPR) motifs of FANCG are required for assembly of the BRCA2/D1-D2-G-X3 complex, FANCD2 monoubiquitylation and phleomycin resistance.

James B Wilson1, Eric Blom, Ryan Cunningham, Yuxuan Xiao, Gary M Kupfer, Nigel J Jones.   

Abstract

The Fanconi anaemia (FA) FANCG protein is an integral component of the FA nuclear core complex that is required for monoubiquitylation of FANCD2. FANCG is also part of another protein complex termed D1-D2-G-X3 that contains FANCD2 and the homologous recombination repair proteins BRCA2 (FANCD1) and XRCC3. Formation of the D1-D2-G-X3 complex is mediated by serine-7 phosphorylation of FANCG and occurs independently of the FA core complex and FANCD2 monoubiquitylation. FANCG contains seven tetratricopeptide repeat (TPR) motifs that mediate protein-protein interactions and here we show that mutation of several of the TPR motifs at a conserved consensus residue ablates the in vivo binding activity of FANCG. Expression of mutated TPR1, TPR2, TPR5 and TPR6 in Chinese hamster fancg mutant NM3 fails to functionally complement its hypersensitivities to mitomycin C (MMC) and phleomycin and fails to restore FANCD2 monoubiquitylation. Using co-immunoprecipitation analysis, we demonstrate that these TPR-mutated FANCG proteins fail to interact with BRCA2, XRCC3, FANCA or FANCF. The interactions of other proteins in the D1-D2-G-X3 complex are also absent, including the interaction of BRCA2 with both the monoubiquitylated (FANCD2-L) and non-ubiquitylated (FANCD2-S) isoforms of FANCD2. Interestingly, a mutation of TPR7 (R563E), that complements the MMC and phleomycin hypersensitivity of human FA-G EUFA316 cells, fails to complement NM3, despite the mutated FANCG protein co-precipitating with FANCA, BRCA2 and XRCC3. Whilst interaction of TPR7-mutated FANCG with FANCF does appear to be reduced in NM3, FANCD2 is monoubiquitylated suggesting that sub-optimal interactions of FANCG in the core complex and the D1-D2-G-X3 complex are responsible for the observed MMC- and phleomycin-hypersensitivity, rather than a defect in FANCD2 monoubiquitylation. Our data demonstrate that FANCG functions as a mediator of protein-protein interactions and is vital for the assembly of multi-protein complexes including the FA core complex and the D1-D2-G-X3 complex. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20450923      PMCID: PMC2903733          DOI: 10.1016/j.mrfmmm.2010.04.003

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  68 in total

1.  Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems.

Authors:  Susan M Gordon; Manuel Buchwald
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

2.  Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM.

Authors:  Alberto Ciccia; Chen Ling; Rachel Coulthard; Zhijiang Yan; Yutong Xue; Amom Ruhikanta Meetei; El Houari Laghmani; Hans Joenje; Neil McDonald; Johan P de Winter; Weidong Wang; Stephen C West
Journal:  Mol Cell       Date:  2007-02-09       Impact factor: 17.970

3.  FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway.

Authors:  Chen Ling; Masamichi Ishiai; Abdullah Mahmood Ali; Annette L Medhurst; Kornelia Neveling; Reinhard Kalb; Zhijiang Yan; Yutong Xue; Anneke B Oostra; Arleen D Auerbach; Maureen E Hoatlin; Detlev Schindler; Hans Joenje; Johan P de Winter; Minoru Takata; Amom Ruhikanta Meetei; Weidong Wang
Journal:  EMBO J       Date:  2007-03-29       Impact factor: 11.598

Review 4.  Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins.

Authors:  Weidong Wang
Journal:  Nat Rev Genet       Date:  2007-09-04       Impact factor: 53.242

5.  Fanconi anemia FANCG protein in mitigating radiation- and enzyme-induced DNA double-strand breaks by homologous recombination in vertebrate cells.

Authors:  Kazuhiko Yamamoto; Masamichi Ishiai; Nobuko Matsushita; Hiroshi Arakawa; Jane E Lamerdin; Jean-Marie Buerstedde; Mitsune Tanimoto; Mine Harada; Larry H Thompson; Minoru Takata
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

Review 6.  Cancer in Fanconi anemia, 1927-2001.

Authors:  Blanche P Alter
Journal:  Cancer       Date:  2003-01-15       Impact factor: 6.860

7.  Identification, developmental expression and regulation of the Xenopus ortholog of human FANCG/XRCC9.

Authors:  Stacie Stone; Alexandra Sobeck; Margriet van Kogelenberg; Bendert de Graaf; Hans Joenje; Jan Christian; Maureen E Hoatlin
Journal:  Genes Cells       Date:  2007-07       Impact factor: 1.891

8.  Biallelic inactivation of BRCA2 in Fanconi anemia.

Authors:  Niall G Howlett; Toshiyasu Taniguchi; Susan Olson; Barbara Cox; Quinten Waisfisz; Christine De Die-Smulders; Nicole Persky; Markus Grompe; Hans Joenje; Gerard Pals; Hideyuki Ikeda; Edward A Fox; Alan D D'Andrea
Journal:  Science       Date:  2002-06-13       Impact factor: 47.728

9.  Insights into Fanconi Anaemia from the structure of human FANCE.

Authors:  Ravi K Nookala; Shobbir Hussain; Luca Pellegrini
Journal:  Nucleic Acids Res       Date:  2007-02-18       Impact factor: 16.971

10.  Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair.

Authors:  Agata Smogorzewska; Shuhei Matsuoka; Patrizia Vinciguerra; E Robert McDonald; Kristen E Hurov; Ji Luo; Bryan A Ballif; Steven P Gygi; Kay Hofmann; Alan D D'Andrea; Stephen J Elledge
Journal:  Cell       Date:  2007-04-05       Impact factor: 41.582

View more
  11 in total

Review 1.  Nuclear alpha spectrin: Critical roles in DNA interstrand cross-link repair and genomic stability.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2016-08-01

2.  Functional and physical interaction between the mismatch repair and FA-BRCA pathways.

Authors:  Stacy A Williams; James B Wilson; Allison P Clark; Alyssa Mitson-Salazar; Andrei Tomashevski; Sahana Ananth; Peter M Glazer; O John Semmes; Allen E Bale; Nigel J Jones; Gary M Kupfer
Journal:  Hum Mol Genet       Date:  2011-08-24       Impact factor: 6.150

3.  The functional importance of lamins, actin, myosin, spectrin and the LINC complex in DNA repair.

Authors:  Muriel W Lambert
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-04

Review 4.  Stress and DNA repair biology of the Fanconi anemia pathway.

Authors:  Simonne Longerich; Jian Li; Yong Xiong; Patrick Sung; Gary M Kupfer
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

5.  FANCD2, FANCJ and BRCA2 cooperate to promote replication fork recovery independently of the Fanconi Anemia core complex.

Authors:  Maya Raghunandan; Indrajit Chaudhury; Stephanie L Kelich; Helmut Hanenberg; Alexandra Sobeck
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 6.  DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of Radiosensitivity.

Authors:  Henning Willers; Liliana Gheorghiu; Qi Liu; Jason A Efstathiou; Lori J Wirth; Mechthild Krause; Cläre von Neubeck
Journal:  Semin Radiat Oncol       Date:  2015-05-14       Impact factor: 5.934

Review 7.  Fanconi anaemia and cancer: an intricate relationship.

Authors:  Grzegorz Nalepa; D Wade Clapp
Journal:  Nat Rev Cancer       Date:  2018-01-29       Impact factor: 60.716

8.  Loss of Mitochondrial Localization of Human FANCG Causes Defective FANCJ Helicase.

Authors:  Jagadeesh Chandra Bose K; Bishwajit Singh Kapoor; Kamal Mandal; Shubhrima Ghosh; Raveendra B Mokhamatam; Sunil K Manna; Sudit S Mukhopadhyay
Journal:  Mol Cell Biol       Date:  2020-11-06       Impact factor: 4.272

9.  Towards a molecular understanding of the fanconi anemia core complex.

Authors:  Charlotte Hodson; Helen Walden
Journal:  Anemia       Date:  2012-05-22

Review 10.  Role of RUNX Family Transcription Factors in DNA Damage Response.

Authors:  Ann Sanoji Samarakkody; Nah-Young Shin; Alan B Cantor
Journal:  Mol Cells       Date:  2020-02-29       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.